For health professionals
Lupus is called the Great Mimic for good reason. Across Africa, diagnostic delays of five to ten years are common, and most of those years are spent in front of clinicians. Earlier recognition changes outcomes.
Consider lupus when a patient, most often a woman aged 15 to 45, presents with a constellation rather than a single complaint: arthralgia or arthritis, unexplained fatigue, photosensitive rash, oral or nasal ulcers, serositis, lymphadenopathy, recurrent low-grade fever, cytopenias or proteinuria.
The pattern that matters is symptoms that come and go, recur over months, and cross organ systems, particularly when a patient has already been treated for several unrelated diagnoses.
No single test confirms or excludes lupus. Diagnosis combines clinical features with serology and evidence of organ involvement, interpreted together and over time.
Where rheumatology access is limited, early referral still matters: it establishes the pathway before organ damage accrues. Urinalysis is one of the highest-yield, lowest-cost checks you can do at first suspicion.
Treatment aims to control disease activity at the lowest effective corticosteroid dose, with antimalarial therapy as a backbone and immunosuppression or biologics where indicated.
Adherence in this setting is frequently a cost problem rather than a belief problem. Asking directly about affordability, distance and out-of-pocket burden changes what you learn.
What patients tell us
Our members consistently describe the same turning points. These are the ones clinicians control.
Ten years is a long time to live without answers. There is a particular kind of exhaustion that comes with knowing something is wrong and not being believed.
Aga Khan University Hospital, Mater Hospital, Kenyatta National Hospital and the Nairobi Arthritis Clinic support lupus awareness, specialist rheumatology care and access to quality care. See all partners.
This page is an awareness summary for context, not a clinical guideline. Please follow current national and international clinical guidance and your institution's protocols for diagnosis and management.
If you see patients who might have lupus, we would like to work with you. Training, materials and a patient community are all available at no cost.
